185 related articles for article (PubMed ID: 28199724)
1. Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.
van den Oever IAM; Heslinga M; Griep EN; Griep-Wentink HRM; Schotsman R; Cambach W; Dijkmans BAC; Smulders YM; Lems WF; Boers M; Voskuyl AE; Peters MJL; van Schaardenburg D; Nurmohamed MT
Rheumatology (Oxford); 2017 Sep; 56(9):1472-1478. PubMed ID: 28199724
[TBL] [Abstract][Full Text] [Related]
2. Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis.
van Breukelen-van der Stoep DF; van Zeben D; Klop B; van de Geijn GJ; Janssen HJ; van der Meulen N; De Vries MA; Hazes M; Birnie E; Castro Cabezas M
Rheumatology (Oxford); 2016 Jul; 55(7):1210-6. PubMed ID: 27009825
[TBL] [Abstract][Full Text] [Related]
3. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.
Emanuel G; Charlton J; Ashworth M; Gulliford MC; Dregan A
Heart; 2016 Dec; 102(24):1957-1962. PubMed ID: 27534979
[TBL] [Abstract][Full Text] [Related]
5. [Determining cardiovascular risk in patients with rheumatoid arthritis: waiting for trial outcomes is not recommended].
Nurmohamed MT
Ned Tijdschr Geneeskd; 2011; 155(29):A3485. PubMed ID: 21791135
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factor management in patients with RA compared to matched non-RA patients.
Alemao E; Cawston H; Bourhis F; Al M; Rutten-van Mölken MP; Liao KP; Solomon DH
Rheumatology (Oxford); 2016 May; 55(5):809-16. PubMed ID: 26705329
[TBL] [Abstract][Full Text] [Related]
7. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
[TBL] [Abstract][Full Text] [Related]
8. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
Danninger K; Hoppe UC; Pieringer H
Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis.
An J; Alemao E; Reynolds K; Kawabata H; Solomon DH; Liao KP; Niu F; Cheetham TC
J Rheumatol; 2016 Nov; 43(11):1989-1996. PubMed ID: 27585690
[TBL] [Abstract][Full Text] [Related]
10. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
[TBL] [Abstract][Full Text] [Related]
11. Change in calculated cardiovascular risk due to guideline revision: A cross-sectional study in the Netherlands.
Luymes CH; de Ruijter W; Poortvliet RK; Putter H; van Duijn HJ; Numans ME; Drewes YM; Blom JW; Assendelft WJ
Eur J Gen Pract; 2015; 21(4):217-23. PubMed ID: 26230039
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model.
Willers J; Hahn A
Rheumatol Int; 2012 Dec; 32(12):3741-9. PubMed ID: 22147110
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis.
Sheng X; Murphy MJ; Macdonald TM; Wei L
J Rheumatol; 2012 Jan; 39(1):32-40. PubMed ID: 22045835
[TBL] [Abstract][Full Text] [Related]
15. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.
Gossec L; Salejan F; Nataf H; Nguyen M; Gaud-Listrat V; Hudry C; Breuillard P; Dernis E; Boumier P; Durandin-Truffinet M; Fannius J; Fechtenbaum J; Izou-Fouillot MA; Labatide-Alanore S; Lebrun A; LeDevic P; LeGoux P; Sacchi A; Salliot C; Sparsa L; d'André FL; Dougados M;
Arthritis Care Res (Hoboken); 2013 May; 65(5):712-7. PubMed ID: 23589412
[TBL] [Abstract][Full Text] [Related]
16. Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study.
Metsios GS; Koutedakis Y; Veldhuijzen van Zanten JJ; Stavropoulos-Kalinoglou A; Vitalis P; Duda JL; Ntoumanis N; Rouse PC; Kitas GD
Rheumatology (Oxford); 2015 Dec; 54(12):2215-20. PubMed ID: 26209790
[TBL] [Abstract][Full Text] [Related]
17. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting.
An J; Cheetham TC; Reynolds K; Alemao E; Kawabata H; Liao KP; Solomon DH
Arthritis Care Res (Hoboken); 2016 May; 68(5):629-37. PubMed ID: 26414069
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
Dessein PH; Stanwix AE; Joffe BI
Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
[TBL] [Abstract][Full Text] [Related]
19. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.
van Breukelen-van der Stoep DF; Zijlmans J; van Zeben D; Klop B; van de Geijn GJ; van der Meulen N; Hazes M; Birnie E; Castro Cabezas M
Scand J Rheumatol; 2015; 44(6):443-8. PubMed ID: 26169960
[TBL] [Abstract][Full Text] [Related]
20. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Patel A; Cass A; Peiris D; Usherwood T; Brown A; Jan S; Neal B; Hillis GS; Rafter N; Tonkin A; Webster R; Billot L; Bompoint S; Burch C; Burke H; Hayman N; Molanus B; Reid CM; Shiel L; Togni S; Rodgers A;
Eur J Prev Cardiol; 2015 Jul; 22(7):920-30. PubMed ID: 24676715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
